Drugs / PTI-6D2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00734188 | Jan 2009 → Mar 2010 | metastatic melanoma | Pain Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTI-6D2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00734188 ↗ |
| Route | Intravenous | “Patients will receive an intravenous (IV) infusion of 188Re-PTI-6D2.” NCT00734188 ↗ |